Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Beyond Casgevy, CRISPR Therapeutics continues ... In the realm of in vivo gene editing, CRISPR Therapeutics is progressing with programs such as CTX310 and CTX320, targeting cardiovascular diseases.

ZUG, Switzerland and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq ... on our platform with next-generation gene editing and delivery technologies, which have the potential ...

That view was echoed by Intellia's chief executive, John Leonard, who said the data "underscore[s] the tremendous potential of [the] in vivo CRISPR gene editing therapy" and "sets NTLA-2002 apart ...

The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics pioneering gene-editing therapy Casgevy ... lives and generally don’t survive beyond their late 30s.